Intellectual Property, Patent, Trademark & Copyright Law Updates

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Jan
12
2023
China’s Supreme People’s Court Releases Second Batch of Typical Civil Code Cases Including Piercing the Corporate Veil in a Trademark/Unfair Competition Case Schwegman, Lundberg & Woessner, P.A.
Jan
12
2023
Contingent Statement Doesn’t Unequivocally Abandon Defense of Challenged Claims McDermott Will & Emery
Jan
12
2023
More Delays: Appeal Dismissed under Collateral Order Doctrine McDermott Will & Emery
Jan
12
2023
Protecting Semiconductor Chip Design under the Semiconductor Chip Protection Act of 1984 (SCPA) – Part I (Registration and Inspection) Sheppard, Mullin, Richter & Hampton LLP
Jan
11
2023
IP Rights in Virtual Fashion: Lessons Learned in 2022 and Unanswered Questions Pierce Atwood LLP
Jan
9
2023
EU Design Reform Package: More efficient, Affordable, and Future-proof Design Protection Ahead Squire Patton Boggs (US) LLP
Jan
8
2023
CNIPA Releases Interim Measures for Handling Examination Business Related to the Implementation of the Revised Patent Law Schwegman, Lundberg & Woessner, P.A.
Jan
8
2023
The USPTO Joins WIPO GREEN Foley & Lardner LLP
Jan
6
2023
Perrigo Co. v. Abbvie Inc. - Third Circuit Holds Mutual Release Bars Generic Drug Company’s Antitrust Claim Alleging That “Sham” Patent Infringement Litigation Delayed Generic Drug Launch K&L Gates
Jan
5
2023
New Hope for Patent Owners Who Can’t or Don’t File Formal Responses? Foley & Lardner LLP
Jan
5
2023
5-Month Criminal Detention Sentence for Legal Representative of Chinese IP Agency for Forging TM Documents Schwegman, Lundberg & Woessner, P.A.
Jan
5
2023
Calling All US IP Owners: Submit Your Comments on IP-Lax States McDermott Will & Emery
Jan
5
2023
PTO Update: COVID-19 Prioritized Examination Extended, Non-DOCX Filing Fee Deferred and More McDermott Will & Emery
Jan
5
2023
Burdens Can’t Be Avoided No Matter How They’re Dressed Up McDermott Will & Emery
Jan
5
2023
Litigation Funding Probe Continues to Make Waves McDermott Will & Emery
Jan
5
2023
Artists Are Selling AI-Generated Images of Mickey Mouse to Provoke a Test Case Robinson & Cole LLP
Jan
5
2023
Challenging Inventorship on Summary Judgment? Put a Cap on It McDermott Will & Emery
Jan
5
2023
ANDA Filing Alone Insufficient for Induced Infringement of Method Patent McDermott Will & Emery
Jan
5
2023
Employee Requests to Work Remotely While Abroad: Considerations for Employers Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jan
4
2023
Shanghai Third Intermediate People’s Court Affirms 3-Year Prison Sentence for Counterfeiting “Bordeaux” Collective Trademark Schwegman, Lundberg & Woessner, P.A.
Jan
4
2023
A Royal Pain: Contingent Royalties Held to be Dischargeable in Mallinckrodt Bracewell LLP
Jan
4
2023
Hospitality Trends: 10 Legal Challenges for Companies in 2023 ArentFox Schiff LLP
Jan
4
2023
Unleashing American Innovators Act Slashes USPTO Small Entity Fees Foley & Lardner LLP
Jan
4
2023
IP Protection of NFTs: A Comparative Look at the US and China Squire Patton Boggs (US) LLP
Jan
3
2023
Southern District Magistrate Judge Holds That Pleading Willful Patent Infringement Does Not Require Allegations of “Egregious” Infringing Activity and That Requisite Knowledge May Be Provided by a Prior Complaint in the Same Action Mintz
Jan
2
2023
Unfair Competition – How To Deal With It? Part 2 Squire Patton Boggs (US) LLP
Dec
31
2022
China to Remove Infringing Pharmaceuticals from Procurement Platforms Schwegman, Lundberg & Woessner, P.A.
Dec
29
2022
USPTO Delays Fee For Non-DOCX Applications Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins